U.S. reconsidering deportation orders for patients receiving medical treatment

Following a media firestorm and outcry from patient groups and biopharma executives, the Trump administration has said it will reconsider a policy change that could lead to the deportations of a rare disease patient and about 1,000 other patients who are receiving medical care in the U.S.

Patient groups and biopharma CEOs are demanding that the administration go beyond tentative steps it has taken and put in place assurances that patients receiving life-saving care that is unavailable in their countries can remain in the U.S. ...